Evidence map›Paper›PMID 21330389›Full record

ArticleAJNR. American journal of neuroradiology2011

Potential of integrated [18F] fluorodeoxyglucose positron-emission tomography/CT in identifying vulnerable carotid plaques.

R M Kwee, M T B Truijman, W H Mess, G J J Teule, J W M ter Berg, C L Franke, A G G C Korten, B J Meems, M H Prins, J M A van Engelshoven and 3 more

Abstract read
In one paragraph

Article in AJNR. American journal of neuroradiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Molecular imaging of carotid artery atherosclerosis with PET: a systematic review.European journal of nuclear medicine and molecular imaging · 2020
    Pooled it
  2. Pooled it
  3. European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery · 2018
    Pooled it
  4. Article
  5. Stroke and molecular imaging: a focus on FDG-PET.American journal of nuclear medicine and molecular imaging · 2023
    Review
  6. Review
  7. PET/MRI of atherosclerosis.Cardiovascular diagnosis and therapy · 2020
    Review
  8. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Article
  9. Predictive medicine: towards a multi-parametric imaging for a personal risk stratification.European journal of nuclear medicine and molecular imaging · 2017
    Article
  10. Article
  11. European journal of nuclear medicine and molecular imaging · 2016
    Article
  12. Article
  13. Neuroimaging of the vulnerable plaque.Current vascular pharmacology · 2015
    Review
  14. Molecular imaging in atherosclerosis: FDG PET.Current atherosclerosis reports · 2012
    Review
  15. Article
  16. Role ofWorld journal of nuclear medicine
    Review
  17. Inter-reader agreement ofJRSM cardiovascular disease
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

R M KweeDepartment of Radiology, Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, the Netherlands.
M T B Truijman
W H Mess
G J J Teule
J W M ter Berg
C L Franke
A G G C Korten
B J Meems
M H Prins
J M A van Engelshoven
J E Wildberger
R J van Oostenbrugge
M E Kooi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThere is a need for improved risk stratification of patients with TIA/stroke and carotid atherosclerosis. The purpose of this study was to prospectively investigate the potential of integrated (18)F-FDG PET/MDCT in identifying vulnerable carotid plaques. MATERIALS AND

methodsFifty patients with TIA/stroke with an ipsilateral carotid plaque causing <70% stenosis and a plaque on the contralateral asymptomatic side underwent integrated (18)F-FDG PET/MDCT within 36.1 ± 20.0 days (range, 9-95 days) of the last symptoms. Carotid plaque (18)F-FDG uptake was measured as both the mean and maximum blood-normalized SUV, known as the TBR. Using MDCT, we assessed volumes of vessel wall and individual plaque components.

resultsMean TBR was only significantly larger in the ipsilateral plaques of patients who were imaged within 38 days (1.24 ± 0.04 [SE] versus 1.17 ± 0.05, P = .014). This also accounted for maximum TBR (1.53 ± 0.06 versus 1.42 ± 0.06, P = .015). MDCT-assessed vessel wall and LRNC volumes were larger in ipsilateral plaques of all patients (982.3 ± 121.3 versus 811.3 ± 106.6 mm(3), P = .016; 164.7 ± 26.1 versus 134.3 ± 35.2 mm(3), P = .026, respectively).

conclusionsIn the present study, (18)F-FDG PET only detected significant differences between ipsilateral and contralateral asymptomatic plaques in patients with TIA/stroke who were imaged within 38 days, whereas MDCT detected larger vessel wall and LRNC volumes, regardless of time after symptoms. In view of the substantial overlap in measurements of both sides, it remains to be determined whether the differences we found will be clinically meaningful.

Indexed as

Fluorodeoxyglucose F18AgedCarotid StenosisFeasibility StudiesFemaleHumansMalePositron-Emission TomographyRadiopharmaceuticalsReproducibility of ResultsSensitivity and SpecificityStrokeSubtraction TechniqueTomography, X-Ray ComputedFluorodeoxyglucose F18Radiopharmaceuticals

Identifiers

PMID21330389
PMCPMC7965558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.